Pacific Biosciences of California competitors

Pacific Biosciences of California's competitors include Oxford Nanopore Technologies, Evidation Health, Wellcentive and Acupera
Add company...
Pacific Biosciences of California
PacBio provides sophisticated genomic analysis systems that deliver invaluable insights for scientists who strive to resolve complex genetic challenges.
Oxford Nanopore Technologies
Oxford Nanopore Technologies develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA and proteins.
Evidation Health
Helping partners quantify and optimize health outcomes through advanced analytics of medical, behavioral and contextual data at the patient-consumer level.
Wellcentive
Drives quality improvement, revenue growth, & business transformation for providers, health systems, employers, & payers transitioning to value-based care.
Acupera
Population Health and Care Coordination Technology Empowering Physicians to Improve Patient Outcomes.
Founding Date
Founding Date
2004
Founding Date
2005
Founding Date
2014
Founding Date
2005
Founding Date
2011
Type
Type
Public
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Menlo Park, US HQ
Irvine, US
Locations
Oxford, GB HQ
Locations
Menlo Park, US HQ
Locations
Alpharetta, US HQ
Dallas, US
Chicago, US
Denver, US
Locations
San Francisco, US HQ
Employees
Employees
438
Employees
3073% increase
Employees
996% increase
Employees
1421% increase
Employees
1
Valuation ($)
Valuation ($)
493.2 m
Valuation ($)
1.6 b
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Facebook likes
Facebook likes
228
Facebook likes
1.6 k
Facebook likes
N/A
Facebook likes
316
Facebook likes
41
Twitter followers
Twitter followers
18.2 k
Twitter followers
22.7 k
Twitter followers
1.6 k
Twitter followers
1.5 k
Twitter followers
145

Financial

Revenue (est.)
Revenue (est.)
$93.5m (FY, 2017)
Revenue (est.)
£13.8m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
$58.8m (FY, 2017)
Cost of goods
£7.1m (FY, 2017)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$34.7m (FY, 2017)
Gross profit
£6.7m (FY, 2017)
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Net income
Net income
($92.2m) (FY, 2017)
Net income
(£56.5m) (FY, 2017)
Net income
N/A
Net income
N/A
Net income
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 139.9m (4 months ago)
Latest funding round
$ 10m (about 1 year ago)
Latest funding round
$ 12m (about 4 years ago)
Latest funding round
$ 4m (almost 4 years ago)
Total funding raised
Total funding raised
$ 360m
Total funding raised
$ 765m
Total funding raised
$ 31m
Total funding raised
$ 18.5m
Total funding raised
$ 10m
For sources of this data, please see the company profileDownload Excel

View company profiles

Oxford Nanopore Technologies
HQ
Oxford, GB
Employees
307↑ 3% increase

Oxford Nanopore Technologies develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA and proteins.

View company
Evidation Health
HQ
Menlo Park, US
Employees
99↑ 6% increase

Helping partners quantify and optimize health outcomes through advanced analytics of medical, behavioral and contextual data at the patient-consumer level.

View company
Wellcentive
HQ
Alpharetta, US
Employees
142↑ 1% increase

Drives quality improvement, revenue growth, & business transformation for providers, health systems, employers, & payers transitioning to value-based care.

View company
Acupera
HQ
San Francisco, US
Employees
1

Population Health and Care Coordination Technology Empowering Physicians to Improve Patient Outcomes.

View company